Fig. 1From: Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall studyFlow chart of the study population. Legend: T1, first follow-up visit; T2, second follow-up visit; CU, cognitively unimpaired; aMCI, amnestic mild cognitive impairment; SCD, subjective cognitive decline; naMCI, non-amnestic MCI; ADL, activities of daily living; hsCRP, high-sensitivity C-reactive proteinBack to article page